18th Apr 2007 07:01
Skyepharma PLC18 April 2007 CIRCULAR POSTED TODAY TO SHAREHOLDERS LONDON, UK, APRIL 18, 2007-- SkyePharma PLC (LSE: SKP; NASDAQ: SKYE) announcesthat a Circular containing details of a new long-term incentive plan (the "LTIP") will today be posted to shareholders. The Circular includes a notice convening an Extraordinary General Meeting to beheld at 11.00 a.m. on 4 May 2007 at the offices of Fasken Martineau StringerSaul LLP, 4th Floor, 17 Hanover Square, London, W1S 1HU at which a resolutionwill be proposed to approve the LTIP. For further information please contact: SkyePharma PLC +44 207 491 1777Frank Condella, Chief Executive OfficerKen Cunningham, Chief Operating OfficerPeter Grant, Finance Director Financial Dynamics +44 207 7831 3113David YatesDeborah Scott The Trout Group + 1 617 583 1308Seth Lewis About SkyePharma PLC Using its proprietary drug delivery technologies, SkyePharma develops newformulations of known molecules to provide a clinical advantage and life-cycleextension. The Company has nine approved products in the areas of oral,inhalation and topical delivery that are marketed throughout the world byleading pharmaceutical companies. For more information, visitwww.skyepharma.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L